Abstract

Models of sepsis have been instructive in understanding the sequence of events in animals and, to an extent, in humans with sepsis. Events developing early in sepsis suggest that a hyperinflammatory state exists, accompanied by a buildup of oxidants in tissues reflective of a redox imbalance. Development of immunosuppression and degraded innate and adaptive immune responses are well-established complications of sepsis. In addition, there is robust activation of the complement system, which contributes to the harmful effects of sepsis. These events appear to be associated with development of multiorgan failure. The relevance of animal models of sepsis to human sepsis and the failure of human clinical trials are discussed, together with suggestions as to how clinical trial design might be improved.

Highlights

  • Introduction suggest that a hyperinflammatory state exists, accompanied by a buildup of oxidants in tissues reflective of a redox imbalance

  • Polysaccharide (LPS) from Gram negative bacteria, lipoteichoic danger-associated molecular patterns (DAMPs) are the ‘alarmins’ that were recently described (Bianchi, acid from Gram positive bacteria] that interact with toll-like 2007; Oppenheim et al, 2007; Yang et al, 2009) and include cell receptors (TLRs) to trigger inflammatory responses

  • When DAMPs appear extracellularly, they react with cell surface receptors or multiple bone fractures and soft tissue injury), ischemia- with other proteins or substrates (e.g. ATPases) to trigger perfusion injury and haemorrhagic shock

Read more

Summary

New approaches to the study of sepsis

Polysaccharide (LPS) from Gram negative bacteria, lipoteichoic DAMPs are the ‘alarmins’ that were recently described (Bianchi, acid from Gram positive bacteria] that interact with toll-like 2007; Oppenheim et al, 2007; Yang et al, 2009) and include cell receptors (TLRs) to trigger inflammatory responses More constituents such as granulolysins, defensins, lactoferrin, recently, it has been discovered in cases of ‘sterile infection’ that a sepsis-like condition can develop (Chen & Nunez, 2010). When DAMPs appear extracellularly, they react with cell surface receptors or multiple bone fractures and soft tissue injury), ischemia- with other proteins or substrates (e.g. ATPases) to trigger perfusion injury and haemorrhagic shock Stages of clinical sepsis are sepsis (accompanied by a systemic response to infection including fever, neutrophilia, tachycardia, increased breathing rate, etc.); severe sepsis and systemic inflammatory response syndrome (SIRS); multiorgan failure (MOF) involving lungs, liver, kidneys, heart; septic shock.

TLRs Cell surface
Animal models of sepsis
The hyperinflammatory response in sepsis
Use of immunostimulants in sepsis
Extracellular Plasma membrane
The future
Findings
Pending issues

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.